Thoracic Cancer International Highlights from ESMO, ASTRO & WCLC 2024-Part1

Описание: Description:
Join us for Day 1 of TOGA’s Post-International Conference Highlights 2024, as we explore the cutting-edge developments in advanced-stage lung cancer showcased at the 2024 International Association for the Study of Lung Cancer (WCLC), European Society for Medical Oncology (ESMO) Congress and American Society for Radiation Oncology (ASTRO) Annual Meeting.

Medical oncology highlights: targeted therapies for advanced-stage non-small cell lung cancer (NSCLC) with a focus on HER2-activating mutations.

Immunotherapy in advanced lung cancer: where we stand and what’s emerging.

Radiotherapy clinical trial updates from WCLC, ESMO and ASTRO 2024

Expert panel discussion with leading clinicians and researchers sharing real-world implications for Australian local practice.

Speakers:

Prof Ben Solomon – Advanced-stage lung cancer overview

Prof Ken O’Byrne – Targeted therapies in advanced NSCLC

Dr Lucy Corke – Immunotherapy in advanced lung cancer

A/Prof Fiona Hegi-Johnson – Radiotherapy trials highlights


Microsatellite Symposium: Dr Venessa Chin (chair), Prof Wendy Cooper, A/Prof Tim Clay, Prof Nick Pavlakis – focused on HER2-mutant NSCLC (ADCs, TKIs, detection)


Date & Time of original recorded event:
Tuesday 15 October 2024 • 6:30 pm–8:15 pm AEST
More information:
Visit TOGA’s event page for full details and the program: thoraciconcology.org.au/events/toga-post-international-conference-highlights-2024

Who should watch:
Researchers, oncologists, radiation oncologists, thoracic surgeons, allied health professionals and anyone involved in lung cancer care who wants to stay at the forefront of emerging therapies and clinical trial data.
#lungcancer #NSCLC #HER2 #immunotherapy #radiotherapy #TOGA2024